Abstract
In this article, the author reviews the historical aspects of the development of neuroprotective drugs including a oxygen radical scavenger, NXY-059 and discusses the missing steps in translating bone marrow stromal cell (BMSC) transplantation for cerebral stroke from laboratory to clinic. Furthermore, the authors describes what we should scientifically clarify to apply BMSC transplantation therapy into the patients with cerebral stroke.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.